Literature DB >> 27910071

PI3K/PTEN/AKT Genetic Mouse Models of Endometrial Carcinoma.

Ayesha Joshi1, Lora Hedrick Ellenson2.   

Abstract

The PI3K/PTEN/AKT pathway is the most frequently mutated pathway in endometrial carcinoma. Mouse models are invaluable tools to understand, at the molecular level, the contributions of components of this pathway towards initiation and progression of endometrial carcinoma. This chapter summarizes results of germline and tissue specific knockout mouse models generated to understand how mutations in components of this pathway lead to development of carcinoma and its interactions with other frequently altered pathways like mismatch repair and estrogen signaling. The mouse models show that loss of both alleles of Pten is necessary and sufficient for complex atypical hyperplasia (CAH) to develop but insufficient for progression to carcinoma. Additional events like mutations in Pik3ca or mismatch repair deficiency are required for progression to carcinoma. The models show that the interaction between Pten and estrogen signaling is complex. In the absence of estrogen, Pten loss is sufficient for development of CAH. Additionally, lack of ERα on a background of Pten loss leads to the development of carcinoma.

Entities:  

Keywords:  ERalpha; Mlh1; Mouse models; Pik3ca; Pten

Mesh:

Substances:

Year:  2017        PMID: 27910071     DOI: 10.1007/978-3-319-43139-0_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  3 in total

Review 1.  Endometrial cancer.

Authors:  Vicky Makker; Helen MacKay; Isabelle Ray-Coquard; Douglas A Levine; Shannon N Westin; Daisuke Aoki; Ana Oaknin
Journal:  Nat Rev Dis Primers       Date:  2021-12-09       Impact factor: 65.038

2.  Fbxw7 is a driver of uterine carcinosarcoma by promoting epithelial-mesenchymal transition.

Authors:  Ileana C Cuevas; Subhransu S Sahoo; Ashwani Kumar; He Zhang; Jill Westcott; Mitzi Aguilar; Jeremy D Cortez; Stephanie A Sullivan; Chao Xing; D Neil Hayes; Rolf A Brekken; Victoria L Bae-Jump; Diego H Castrillon
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-26       Impact factor: 11.205

3.  TRIM27 promotes the development of esophagus cancer via regulating PTEN/AKT signaling pathway.

Authors:  Liang Ma; Ninghua Yao; Ping Chen; Zhixiang Zhuang
Journal:  Cancer Cell Int       Date:  2019-11-08       Impact factor: 5.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.